Plenary lectures

Naveed Sattar is a Glasgow Graduate, but brought up in modest Lanarkshire ! He is clinically active, and has helped advance understanding and management of diabetes, cardiovascular disease, and obesity. His current research increasingly focuses on intentional weight loss interventions – esp. incretins – and on clarifying how obesity contributes to the development or progression of multiple adverse health outcomes, including diabetes, cardiovascular conditions, and autoimmune diseases such as psoriasis and psoriatic arthritis. He has received numerous prestigious national and international awards recognising his scientific contributions and has over 1600 published papers. He has also contributed to multiple national and international clinical guidelines, including on the cardiometabolic consequences of autoimmune disease. He serves as an Associate Editor for Diabetes Care and Editorial Consultant for The Lancet. He contributes to new health initiatives in the Scottish Health Service and is currently Chair of the Obesity Healthcare Goals programme for the UK government.

Prof Sir Munir Pirmohamed (MB ChB, PhD, FRCPE, FRCP, FFPM. FRSB, FBPhS, FMedSci ) is currently David Weatherall Chair of Medicine at the University of Liverpool, and a Consultant Physician at the Royal Liverpool University Hospital. He also holds the only NHS Chair of Pharmacogenetics in the UK. He is Director of the Centre for Drug Safety Sciences, and Director of the Wolfson Centre for Personalised Medicine. He also leads the Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx). He was awarded a Knights Bachelor in the Queen’s Birthday Honours list in 2015. He is an inaugural NIHR Senior Investigator, and Fellow of the Academy of Medical Sciences in the UK. He is Chair of the Commission on Human Medicines. He is also a Medical Trustee for the British Heart Foundation. Past appointments include President of the British Pharmacological Society, President of the Association of Physicians, Member of the Governing Council of the MRC and Non-Executive Director NHS England.
His research focuses on personalised medicine in order to optimise drug efficacy and minimise toxicity, move discoveries from the lab to the clinic, and from clinic to application.